Patrick S Gibbons, MD
Internal Medicine · Vacaville
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 22 years
- University of California, Geffen School of Medicine, 2004
Offices
2 locations · Permanente Medical Group Inc · 10,928 clinicians in this group
Hospitals listed: Kaiser Foundation Hospital - Vacaville. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Gibbons’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A92569 · Current
Licensed to practise in California · since 2005 · expires 2026-10-31 · University of California, Los Angeles School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Kaiser Foundation Hospital - VacavilleVacaville, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Kaiser Permanente, which runs 41 hospitals in 3 statesPatients rate it 4 of 5 · 74% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Kaiser Foundation Hospital - Vacaville
Behind the star rating — Deaths: 0 better, 1 the same, 0 worse of 1 measures. Safety: 0 better, 6 the same, 0 worse of 6 measures. Readmissions: 0 better, 1 the same, 0 worse of 1 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.03 (0 to 2.11) · 116 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.45 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate for stroke patientsComplications and deaths | 15.9 · 97 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.6 · 1,636 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.44) · 535 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.05 to 0.48) · 517 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.25 (0.7 to 5.8) · 152 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.67 (0 to 3.4) · 47 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.55 (0.86 to 4.25) · 153 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.91 (0 to 18.84) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (0.84 to 9.45) · 43 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.22 to 3.28) · 30 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.44 (0 to 1.57) · 508 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 47 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.289 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.451 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.668 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 2.438 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 28 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21 · 226 cases | None | Jul 2023 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.8 · 304 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 48 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 78 cases | None | Jul 2023 – Jun 2025 |
What patients said (1,058 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 77% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 92% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 51% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$3,420
Medicare paid this office $3,420 for 21 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $2,199 | $67 |
Who their Medicare patients are
21 Original Medicare patients in 2024. Average age 69 · Health risk score 2.73. Above the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Diabetes 57% · Chronic kidney disease 57%.
The office billed $9,753, Medicare allowed $4,292 and paid $3,420; for 45 services of 5 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 21 | 45 | 69 | 2.73 | $9,753 | $3,420 |
| 2022 | 16 | 42 | 66 | 3.11 | $7,492 | $2,711 |
| 2021 | 12 | 24 | 71 | 0.89 | $4,151 | $1,506 |
| 2020 | 20 | 44 | 68 | 3.28 | $7,314 | $2,961 |
| 2019 | 20 | 47 | 68 | 3.81 | $9,532 | $3,116 |
| 2018 | 23 | 55 | 67 | 3.80 | $10,567 | $3,518 |
| 2017 | 20 | 58 | 73 | 2.91 | $11,622 | $3,544 |
| 2016 | 29 | 82 | 66 | 3.33 | $17,474 | $5,036 |
| 2015 | 23 | 104 | 68 | 2.52 | $17,234 | $4,987 |
| 2014 | 20 | 3,923 | 63 | 2.99 | $25,264 | $6,689 |
| 2013 | 65 | 197 | 76 | 2.67 | $51,878 | $14,905 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2020: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,636 | $63 |
2019: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $2,003 | $63 |
2018: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,933 | $60 |
2017: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $2,119 | $59 |
2016: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $3,897 | $60 |
2015: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $3,314 | $61 |
2014: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $2,894 | $60 |
2013: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 43 | $6,579 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $3,614 | $88 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $2,028 | $119 |
Drugs they prescribed that Part D paid
$5,591
Pharmacies billed $5,591 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
129 generic and fewer than 11 brand-name prescriptions · $5,591 in drug cost · 34 antibiotic prescriptions to 23 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 143 | 57 | None | None | $5,591 |
| 2023 | 152 | 52 | None | 12% | $3,955 |
| 2022 | 132 | 59 | None | 14% | $6,780 |
| 2021 | 211 | 73 | None | None | $8,235 |
| 2020 | 256 | 94 | None | None | $11,641 |
| 2019 | 334 | 100 | None | 22% | $18,552 |
| 2018 | 296 | 110 | None | None | $15,478 |
| 2017 | 333 | 108 | 5% (16) | None | $20,148 |
| 2016 | 289 | 103 | None | 24% | $15,577 |
| 2015 | 428 | 148 | 6% (24) | None | $19,380 |
| 2014 | 429 | 152 | 6% (25) | 18% | $20,432 |
| 2013 | 310 | 111 | 8% (25) | 20% | $16,007 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Cefpodoxime Proxetil | 17 | $291 | $17 |
| Metoprolol | 15 | $156 | $10 |
| Furosemide | 13 | $135 | $10 |
2022: 2 drugs
| Atorvastatin | 11 | $128 | $12 |
| Metoprolol | 13 | $110 | $8 |
2021: 3 drugs
| Cefpodoxime Proxetil | 14 | $313 | $22 |
| Pantoprazole | 13 | $145 | $11 |
| Atorvastatin | 11 | $114 | $10 |
2020: 3 drugs
| Furosemide | 20 | $228 | $11 |
| Metoprolol | 23 | $197 | $9 |
| Atorvastatin | 11 | $148 | $13 |
2019: 8 drugs
| Atorvastatin | 19 | $492 | $26 |
| Furosemide | 30 | $402 | $13 |
| Pantoprazole | 24 | $382 | $16 |
| Cefpodoxime Proxetil | 13 | $359 | $28 |
| Warfarin | 23 | $330 | $14 |
| Metoprolol | 19 | $176 | $9 |
| Doxycycline Monohydrate | 13 | $123 | $9 |
| Amlodipine Besylate | 11 | $110 | $10 |
2018: 7 drugs
| Warfarin | 31 | $506 | $16 |
| Atorvastatin | 18 | $453 | $25 |
| Cefpodoxime Proxetil | 14 | $386 | $28 |
| Furosemide | 28 | $316 | $11 |
| Metoprolol | 15 | $131 | $9 |
| Carvedilol | 13 | $102 | $8 |
| Glipizide | 12 | $98 | $8 |
2017: 6 drugs
| Atorvastatin | 21 | $659 | $31 |
| Warfarin | 36 | $560 | $16 |
| Cefpodoxime Proxetil | 11 | $479 | $44 |
| Gabapentin | 13 | $460 | $35 |
| Furosemide | 16 | $183 | $11 |
| Metoprolol | 16 | $129 | $8 |
2016: 4 drugs
| Warfarin | 40 | $549 | $14 |
| Furosemide | 25 | $305 | $12 |
| Metoprolol | 27 | $225 | $8 |
| Carvedilol | 12 | $100 | $8 |
2015: 10 drugs
| Warfarin | 42 | $488 | $12 |
| Atorvastatin | 15 | $482 | $32 |
| Amoxicillin-Clavulanate Potass | 16 | $420 | $26 |
| Pantoprazole | 16 | $335 | $21 |
| Metoprolol | 31 | $284 | $9 |
| Furosemide | 22 | $274 | $12 |
| Prednisone | 17 | $263 | $15 |
| Hydrocodone-Acetaminophen | 12 | $218 | $18 |
| Levofloxacin | 18 | $131 | $7 |
| Carvedilol | 13 | $123 | $9 |
2014: 9 drugs
| Warfarin | 43 | $583 | $14 |
| Atorvastatin | 19 | $459 | $24 |
| Pantoprazole | 17 | $459 | $27 |
| Furosemide | 34 | $423 | $12 |
| Levofloxacin | 19 | $264 | $14 |
| Prednisone | 14 | $166 | $12 |
| Lisinopril | 16 | $161 | $10 |
| Metoprolol | 17 | $144 | $8 |
| Ciprofloxacin | 17 | $144 | $8 |
2013: 10 drugs
| Clopidogrel | 15 | $582 | $39 |
| Atorvastatin | 14 | $243 | $17 |
| Warfarin | 14 | $157 | $11 |
| Hydrocodone-Acetaminophen | 14 | $154 | $11 |
| Pantoprazole | 11 | $139 | $13 |
| Prednisone | 14 | $139 | $10 |
| Lisinopril | 15 | $135 | $9 |
| Ciprofloxacin | 15 | $117 | $8 |
| Furosemide | 14 | $102 | $7 |
| Levofloxacin | 11 | $79 | $7 |
Money from drug and device companies
$33 in 2023
| 2023 | 1 | 2 | None | $33 |
| 2019 | 1 | 2 | None | $43 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Pfizer | Prevnar 13 | $33 | 2 payments
|
See all 2 published payments
| Pfizer | Meals · 2023-02-06 | Prevnar 13 | $16 |
| Pfizer | Meals · 2023-01-28 | Prevnar 13 | $17 |
See earlier years (2019)
2019: $43
| Gilead Sciences | None | $43 | 2 payments
|
Professional record
- NPI
- 1336344910
- Licence
- CA A92569California A92569: Current · expires 2026-10-31
- Trained
- University of California, Geffen School of Medicine, 2004 · 22 years ago
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 204 Durand Way, Palo Alto, CA, 94304
- NPI first listed
- 2007-06-15
- NPI last updated
- 2022-02-11
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.